Irish biotech Aerska raises $39m Series A to deliver RNA meds to the brain

Irish biotech Aerska raises $39m Series A to deliver RNA meds to the brain

Having emerged from stealth in October 2025 with a seed round of $21m, Irish RNA biotech Aerska has raised a $39m series A funding round.

Read more: Irish biotech Aerska raises $39m Series A to deliver RNA meds to the brain